Wikidata

(Q33671152)

English

Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study

scientific article

In more languages

Statements

title
Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20735258
retrieved
28 July 2017
author name string
Rebekah L Puls
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
20735258
retrieved
28 July 2017
Preeyaporn Srasuebkul
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
20735258
retrieved
28 July 2017
Kathy Petoumenos
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
20735258
retrieved
28 July 2017
Christoph Boesecke
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
20735258
retrieved
28 July 2017
Chris Duncombe
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
20735258
retrieved
28 July 2017
Waldo H Belloso
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
20735258
retrieved
28 July 2017
Anchalee Avihingsanon
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
20735258
retrieved
28 July 2017
Brian Gazzard
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
20735258
retrieved
28 July 2017
David A Cooper
series ordinal
11
1 reference
stated in
Europe PubMed Central
PubMed ID
20735258
retrieved
28 July 2017
Altair Study Group
series ordinal
13
1 reference
stated in
Europe PubMed Central
PubMed ID
20735258
retrieved
28 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33671152&oldid=1953400033"